← Leaderboards
Michael C Keefer
University Of Rochester
$52,523,093
Attributed
$57,601,174
Total exposure
16
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$57,601,174 · 16
By mechanism
UM1$23,775,473 · 1
U01$20,670,580 · 2
P01$11,606,890 · 1
P30$1,135,492 · 1
M01$299,739 · 10
N01$113,000 · 1
Top collaborators
- Stephen Dewhurst4 shared
- Paul R Bohjanen2 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Joseph Christopher Holt$4,059,253
- B. Paige Lawrence$23,471,485
- Jean M Bidlack$6,851,551
- Thomas A Gasiewicz$24,015,628
- Stephen Dewhurst$37,837,871
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHiv InfectionsClinical TrialsLaboratoriesUniversitiesResearch PersonnelProgramsAreaHiv Vaccine Trials NetworkAids/Hiv ProblemCommunicable DiseasesClinical Research SitePerformanceTrainingLeadershipHiv VaccineClinical Trials UnitCommunity Health EducationResearch ActivityProtocols DocumentationAcquired Immunodeficiency SyndromeTranslational ResearchNational Institute Of Allergy And Infectious DiseaseEnrollment
Grant awards (53)
University of Rochester HIV/AIDS Clinical Trials Unit$1,817,383
UM1 · FY2025 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit Administrative Supplement$1,094,709
UM1 · FY2025 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,831,085
UM1 · FY2024 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,757,954
UM1 · FY2023 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,892,537
UM1 · FY2022 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,762,495
UM1 · FY2021 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,515,664
UM1 · FY2020 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$290,519
UM1 · FY2020 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,633,686
UM1 · FY2019 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,166,421
UM1 · FY2018 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,166,422
UM1 · FY2017 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,189,150
UM1 · FY2016 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,135,210
UM1 · FY2015 · AI · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,692,796
UM1 · FY2014 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$1,597,142
UM1 · FY2013 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$2,158,520
UM1 · FY2012 · AI · contact PI
Clinical Science Core$164,538
P30 · FY2012 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$73,780
UM1 · FY2012 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$2,228,690
U01 · FY2011 · AI · contact PI
Clinical Science Core$364,886
P30 · FY2011 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$2,357,844
U01 · FY2010 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$240,557
U01 · FY2010 · AI · contact PI
Clinical Science Core$185,918
P30 · FY2010 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$2,317,443
U01 · FY2009 · AI · contact PI
Clinical Science Core$250,542
P30 · FY2009 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$2,248,523
U01 · FY2008 · AI · contact PI
Clinical Science Core$169,608
P30 · FY2008 · AI · contact PI
HSV-1 Amplicon Vectors for HIV Vaccine Delivery$2,583,049
P01 · FY2007 · AI · contact PI
HSV-1 Amplicon Vectors for HIV Vaccine Delivery$2,586,750
P01 · FY2006 · AI · contact PI
HIV VACCINE CLINICAL TRIALS UNIT$961,319
U01 · FY2006 · AI · contact PI
HSV-1 Amplicon Vectors for HIV Vaccine Delivery$2,530,347
P01 · FY2005 · AI
HIV VACCINE CLINICAL TRIALS UNIT$1,892,788
U01 · FY2005 · AI
PHASE I/II CLINICAL TRIAL TO EVALUATE SAFETY AND IMMUNOGENICITY OF HIV VACCINES$51,874
M01 · FY2005 · RR
CLINICAL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF HIV-1 DNA VACCINE$46,612
M01 · FY2005 · RR
A PHASE I TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENCITY OF RMVA-HIV VACCINE$30,071
M01 · FY2005 · RR
A PHASE 1 CLINICAL TRIAL TO EVALUATE SAFETY AND IMMUNOGENICITY OF HIV VACCINE$29,320
M01 · FY2005 · RR
TRIAL OF AN ALPHAVIRUS REPLICON HIV SUBTYPE C GAG VACCINE IN HEALTHY SUBJECTS$9,022
M01 · FY2005 · RR
TRIAL TO EVALUATE HIGH DOSE LIVE RECOMBINANT CANARYPOX ALVAC VACCINE (VCP1452)$5,262
M01 · FY2005 · RR
HSV-1 Amplicon Vectors for HIV Vaccine Delivery$2,491,559
P01 · FY2004 · AI
HIV VACCINE CLINICAL TRIALS UNIT$1,518,955
U01 · FY2004 · AI
AVEG 203: PHASE II TRIAL OF COMBINED REGIMEN USING ALVAC VCP1452, AIDSVAX B/$51,031
M01 · FY2004 · RR
TRIAL OF ALPHAVIRUS REPLICON HIV SUBTYPE C GAG VACCINE$49,922
M01 · FY2004 · RR
HSV-1 Amplicon Vectors for HIV Vaccine Delivery$34,772
P01 · FY2004 · AI
Trial to Evaluate High Dose Live Recombinant CanaryPox ALVAC Vaccine (vCP1452)$16,641
M01 · FY2004 · RR
Trial of a Combination HIV Vaccine Formulated with AS02A Given IM in HIV-1 Uninf$9,984
M01 · FY2004 · RR
HIV VACCINE CLINICAL TRIALS UNIT$1,388,773
U01 · FY2003 · AI
HSV-1 Amplicon Vectors for HIV Vaccine Delivery$1,380,413
P01 · FY2003 · AI
HIV VACCINE CLINICAL TRIALS UNIT$1,805,507
U01 · FY2002 · AI
AVEG 032--HIV1 SF2 RECOMBI P24 SUBUNIT VACCINE$0
M01 · FY2002 · RR
HIV VACCINE CLINICAL TRIALS UNIT$1,820,497
U01 · FY2001 · AI
HIV VACCINE CLINICAL TRIALS UNIT$1,889,684
U01 · FY2000 · AI
AIDS VACCINE EVALUATION UNITS$113,000
N01 · FY2000 · AI
AVEG 032--HIV1 SF2 RECOMBI P24 SUBUNIT VACCINE$0
M01 · FY2000 · RR